leadership is the sole category represented across all 1 tracked stories. MindMaze Therapeutics is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 6.6 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Glooko
leadership is the sole category represented across all 1 tracked stories. MindMaze Therapeutics is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 6.6 in the same window. Each story carries 2 original sources on average, compared with 2.3 for the broader beat in this window. Glooko appears in 1 tracked Startup story from March 12, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 52 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Glooko. Shared-story counts are live from our verified record — not editorial picks.
MindMaze Therapeutics has named healthtech veteran Zach Henderson as its new CEO, signaling a strategic shift toward aggressive global commercialization. Henderson, formerly of Glooko, succeeds founder Tej Tadi as the neurotech unicorn seeks to expand its digital rehabilitation platform across international markets.
Glooko is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.